Ascendis Pharma AS (ASND)
122.00
-4.51
(-3.56%)
USD |
NASDAQ |
Nov 18, 16:00
121.99
-0.01
(-0.01%)
After-Hours: 20:00
Ascendis Pharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 75.14 |
| September 28, 2023 | 75.75 |
| September 27, 2023 | 75.05 |
| September 26, 2023 | 75.16 |
| September 25, 2023 | 76.19 |
| September 22, 2023 | 75.84 |
| September 21, 2023 | 76.14 |
| September 20, 2023 | 76.27 |
| September 19, 2023 | 78.25 |
| September 18, 2023 | 81.40 |
| September 15, 2023 | 81.90 |
| September 14, 2023 | 82.48 |
| September 13, 2023 | 79.96 |
| September 12, 2023 | 81.82 |
| September 11, 2023 | 79.83 |
| September 08, 2023 | 77.85 |
| September 07, 2023 | 82.25 |
| September 06, 2023 | 82.94 |
| September 05, 2023 | 79.57 |
| September 01, 2023 | 78.40 |
| August 31, 2023 | 78.20 |
| August 30, 2023 | 77.03 |
| August 29, 2023 | 79.71 |
| August 28, 2023 | 78.56 |
| August 25, 2023 | 78.91 |
| Date | Value |
|---|---|
| August 24, 2023 | 76.48 |
| August 23, 2023 | 74.98 |
| August 22, 2023 | 73.80 |
| August 21, 2023 | 74.59 |
| August 18, 2023 | 72.17 |
| August 17, 2023 | 70.14 |
| August 16, 2023 | 71.72 |
| August 15, 2023 | 73.79 |
| August 14, 2023 | 73.56 |
| August 11, 2023 | 73.63 |
| August 10, 2023 | 72.22 |
| August 09, 2023 | 75.74 |
| August 08, 2023 | 75.06 |
| August 07, 2023 | 73.16 |
| August 04, 2023 | 77.22 |
| August 03, 2023 | 75.25 |
| August 02, 2023 | 72.83 |
| August 01, 2023 | 73.09 |
| July 31, 2023 | 71.92 |
| July 28, 2023 | 74.27 |
| July 27, 2023 | 69.85 |
| July 26, 2023 | 69.14 |
| July 25, 2023 | 69.61 |
| July 24, 2023 | 69.01 |
| July 21, 2023 | 71.20 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.799
Minimum
Mar 11 2022
82.94
Maximum
Sep 06 2023
15.54
Average
8.683
Median
Price to Book Value Benchmarks
| Novo Nordisk AS | 24.57 |
| Evaxion Biotech AS | 122.87 |
| Trinity Biotech PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.192 |
| NuCana PLC | 0.673 |
Price to Book Value Related Metrics
| PS Ratio | 19.63 |
| Price | 122.00 |
| Earnings Yield | -6.64% |
| Market Cap | 7.291B |